Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Agamree 40 mg/ml oral suspension {equilateral_black_triangle}

Active Ingredient:
vamorolone
Company:  
Santhera (UK) Limited See contact details
ATC code: 
H02AB18
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Risk Materials HCP Med Info
{arrow_left}
{arrow_right}
The Patient Information Leaflet (PIL) is the leaflet included in the pack with a medicine.
{info_black}
Last updated on emc: 19 Sep 2024

{equilateral_black_triangle} This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information.

{pdf} View or print the patient leaflet as PDF
Santhera (UK) Limited
Company image
Address
1 Chamberlain Square Cs, Birmingham, B3 3AX, UK
Telephone
+44 (0)1753 972 351
E-mail
[email protected]
WWW
www.santhera.com
Medical Information e-mail
[email protected]